BIOMEDICAL CATALYST FUND

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.

#Financial #More

BIOMEDICAL CATALYST FUND

Industry:
Biotechnology

Status:
Active


Investments List

Date Company Article Money raised
2022-08-24 Gripable Biomedical Catalyst Fund investment in Grant - Gripable 800 K GBP
2022-03-30 Invizius Biomedical Catalyst Fund investment in Grant - Invizius 1000 K GBP
2021-02-18 Vinehealth Biomedical Catalyst Fund investment in Grant - Vinehealth 1000 K GBP
2019-07-10 SleepCogni Biomedical Catalyst Fund investment in Grant - SleepCogni 234 K GBP
2019-01-30 MediSieve Biomedical Catalyst Fund investment in Grant - MediSieve 1.56 M GBP
2014-05-01 Calcivis Biomedical Catalyst Fund investment in Grant - Calcivis 1.3 M GBP
2014-03-26 Adaptimmune Biomedical Catalyst Fund investment in Grant - Adaptimmune 3.5 M USD
2013-07-31 Summit Therapeutics Biomedical Catalyst Fund investment in Grant - Summit Therapeutics 2.4 M GBP
2013-05-30 Atopix Therapeutics Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics 1.7 M USD
2012-11-06 Arecor Biomedical Catalyst Fund investment in Grant - Arecor 785 K GBP

More informations about "Biomedical Catalyst Fund"

Innovate UK - Biomedical Catalyst - Innovate UK Business Connect

Biomedical Catalyst is technology agnostic; we want to fund a variety of projects across different markets, technologies, strands and themes. How it works By awarding grants to UK-based …See details»

Biomedical Catalyst Fund - Crunchbase Investor Profile

Biomedical Catalyst Fund may be growing as evidenced by the recent award of a £405K Innovate UK Biomedical Catalyst Grant to SolasCure, which is indicative of active investment in the …See details»

Biomedical Catalyst | BIA - bioindustry.org

The BIA has been the driving force in making a compelling case for the interests of UK life science SMEs in Whitehall and Westminster. Your campaign to re-fund the Biomedical Catalyst, with …See details»

Biomedical Catalyst 2024 Round 1: Industry-led R&D

Sep 2, 2024 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences …See details»

Take on the biggest healthcare challenges: apply for …

Jan 17, 2019 Since 2012, the Biomedical Catalyst has awarded over £250 million in grants to more than 300 projects. Previous projects include Calon Cardio and Swansea University, ...See details»

Biomedical Catalyst funding to boost healthcare innovation

Aug 22, 2024 Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism helping small and medium-sized businesses test and develop innovative health and care solutions …See details»

BIOMEDICAL CATALYST

The Biomedical catalyst was launched in 2012, with a provision of Ł240m, for projects running until the end of 2014/15. Following an evaluation, a further Ł100m was announced to fund …See details»

Biomedical Catalyst Fund - Investments, Portfolio & Company Exits

Dec 16, 2022 Biomedical Catalyst Fund 's most notable exits include Immunocore, Summit Therapeutics, and Arecor. Which industries has this organization had the most exits in? Show …See details»

Biomedical catalyst 2022 round two: industry-led R&D – UKRI

Aug 4, 2022 UK registered micro, small or medium-sized enterprises (SME) can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges.See details»

Biomedical Catalyst Fund - raizer.app

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics. Learn which startups Biomedical Catalyst Fund invests in, number of …See details»

Biomedical Catalyst 2023 Round 1: Industry-led R&D

Jan 4, 2023 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences …See details»

Biomedical Catalyst Fund - Crunchbase

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»

£32 million boost for UK biomedical projects

Mar 26, 2015 A total of £350 million in funding has been invested in the Biomedical Catalyst since it was set up in 2011. This latest round of funding brings the total number of awards to …See details»

Biomedical Catalyst 2024 Round One: Industry-Led R&D

Oct 9, 2024 The Biomedical Catalyst 2024 Round One: Industry-Led R&D funding opportunity is open to UK registered SMEs seeking funding to develop innovative solutions for health and …See details»

Biomedical Catalyst 2022 Round 2: Industry-led R&D

Aug 15, 2022 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences …See details»

Biomedical Catalyst Funding Programe in the UK - fundsforNGOs

Deadline: 25-May-22 Innovate UK, part of UK Research and Innovation has announced Biomedical Catalyst funding programme to support UK businesses to test and develop …See details»

Biomedical catalyst 2021: early and late stage awards

Jun 7, 2021 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences …See details»

List of Biomedical Catalyst Fund's 15 Investments ... - Crunchbase

List of Biomedical Catalyst Fund 's 15 Investments, including Alchemab Therapeutics and Gripable. Save Search . Companies . Contacts . Investors ...See details»

Exploring Manufacturing Techniques in Bioceramic Scaffold …

Apr 3, 2025 Scaffolds are fabricated using a diverse range of materials, encompassing both natural and synthetic origins. These materials may include biodegradable polymers, ceramics, …See details»

Great leaders in healthcare | 2025 | Becker's - Becker's Hospital …

Mar 13, 2025 Arbuckle’s leadership of MemorialCare’s innovation fund has led to partnerships with over 50 companies, offering a valuable gateway to accelerate advances in healthcare …See details»